Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population

Autor: Ma, Yuan, Liu, Xiuchun, Zhu, Jingyan, Li, Wanhu, Guo, Liangjun, Han, Xiao, Song, Bao, Cheng, Sensen, Jie, Liu

Lung cancer is a leading cause of cancer-related death in China, with non-small cell lung cancer (NSCLC) comprises the most common form. Co-inhibitory molecules, such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed death 1 (PD-1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::75a3681ed23851894435fe1a1cfe659d
https://europepmc.org/articles/PMC4659076/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population.

Autor: Ma Y; School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250117, Shandong, China ; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China., Liu X; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China., Zhu J; Department of Oncology, Weifang Hospital of Traditional Chinese Medicine Weifang 261000, Shandong, China., Li W; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China., Guo L; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China., Han X; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China., Song B; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China., Cheng S; School of Medicine and Life Sciences, University of Jinan, Shandong Academy of Medical Sciences Jinan 250117, Shandong, China ; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China., Jie L; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences 440 Jiyan Road, Jinan 250117, Shandong, China.

Publikováno v: International journal of clinical and experimental medicine [Int J Clin Exp Med] 2015 Sep 15; Vol. 8 (9), pp. 16585-91. Date of Electronic Publication: 2015 Sep 15 (Print Publication: 2015).